Normal Hemostasis Values in Premature Infants

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07349251

Acronym

PRHEMO

Enrollment

1000

Registered

2026-01-16

Start date

2025-11-24

Completion date

2031-11-24

Last updated

2026-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature Infant, Hemostasis

Keywords

Premature Infant, Neonatal Prematurity, Preterm Infants, Hemostasis

Brief summary

This study aims to retrospectively determine, in a large cohort of apparently healthy children born before 37 weeks of gestation, the expected values of certain hemostasis parameters from birth to 18 months (when they start walking), and to determine whether or not they differ from those of full-term infants.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

0 Months to 18 Months

Healthy volunteers

Inclusion criteria

* Patients aged 18 months or younger for whom a sample was sent to the Hematology Laboratory at Strasbourg University Hospital for measurement of a hemostasis parameter

Exclusion criteria

* Patients with incomplete data * Patients with a congenital hemostasis disorder (hemophilia A or B, von Willebrand disease), a coagulopathy, or hepatocellular insufficiency

Design outcomes

Primary

Measure	Time frame	Description
Normal hemostasis values in premature infants	Up to 6 years	Normal hemostasis values in premature infants will be determined according to the gestational age at birth

Countries

France

Contacts

Primary ContactAgathe HERB, PharmD

agathe.herb@chru-strasbourg.fr33 3 88 12 75 53

Outcome results